6-ketoprostaglandin-e1 and Arteriosclerosis

6-ketoprostaglandin-e1 has been researched along with Arteriosclerosis* in 2 studies

Other Studies

2 other study(ies) available for 6-ketoprostaglandin-e1 and Arteriosclerosis

Article	Year
Prostaglandins and cyclic nucleotides. Modulators of arterial cholesterol metabolism. Biochemical pharmacology, 1985, Feb-01, Volume: 34, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Arteries; Arteriosclerosis; Biological Transport; Cholesterol; Cholesterol Esters; Cyclic AMP; Dinoprostone; Epoprostenol; Humans; In Vitro Techniques; Lipoproteins, LDL; Muscle, Smooth, Vascular; Nucleotides, Cyclic; Prostaglandins; Prostaglandins E; Sterol Esterase; Sterol O-Acyltransferase; Vasodilator Agents	1985
Prostaglandins modulate arterial cholesteryl ester metabolism. Enzyme, 1984, Volume: 32, Issue:4 Cholesterol and cholesteryl esters (CE) are the two major classes of lipids which accumulate in arteries during human arteriosclerosis. Mechanisms responsible for this arterial lipid accretion remain to be fully elucidated. In recent years, we have suggested that prostaglandins may have an important role in the modulation of intracellular arterial CE metabolism through their interaction with cyclic nucleotides. This hypothesis was based on observations that arteriosclerotic arteries produce less prostaglandins, particularly prostacyclin, and have altered CE synthetic and hydrolytic activities as compared to uninvolved arteries. This review is a summary of our present knowledge concerning the role of eicosanoids and cyclic nucleotides in the modulation of enzyme activities responsible for arterial CE synthesis and hydrolysis. Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cyclic AMP; Dinoprostone; Epoprostenol; Humans; Hydrolysis; Muscle, Smooth, Vascular; Prostaglandins; Prostaglandins E	1984

Article

Year

Prostaglandins and cyclic nucleotides. Modulators of arterial cholesterol metabolism.

Biochemical pharmacology, 1985, Feb-01, Volume: 34, Issue:3

Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Arteries; Arteriosclerosis; Biological Transport; Cholesterol; Cholesterol Esters; Cyclic AMP; Dinoprostone; Epoprostenol; Humans; In Vitro Techniques; Lipoproteins, LDL; Muscle, Smooth, Vascular; Nucleotides, Cyclic; Prostaglandins; Prostaglandins E; Sterol Esterase; Sterol O-Acyltransferase; Vasodilator Agents

1985

Prostaglandins modulate arterial cholesteryl ester metabolism.

Enzyme, 1984, Volume: 32, Issue:4

Cholesterol and cholesteryl esters (CE) are the two major classes of lipids which accumulate in arteries during human arteriosclerosis. Mechanisms responsible for this arterial lipid accretion remain to be fully elucidated. In recent years, we have suggested that prostaglandins may have an important role in the modulation of intracellular arterial CE metabolism through their interaction with cyclic nucleotides. This hypothesis was based on observations that arteriosclerotic arteries produce less prostaglandins, particularly prostacyclin, and have altered CE synthetic and hydrolytic activities as compared to uninvolved arteries. This review is a summary of our present knowledge concerning the role of eicosanoids and cyclic nucleotides in the modulation of enzyme activities responsible for arterial CE synthesis and hydrolysis.

Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cyclic AMP; Dinoprostone; Epoprostenol; Humans; Hydrolysis; Muscle, Smooth, Vascular; Prostaglandins; Prostaglandins E

1984